Tumor Microenvironment and Its Role in Modulating Anti-Tumor Immune Responses: A Comprehensive Review

The tumor microenvironment (TME) is a highly dynamic and heterogeneous ecosystem composed of malignant cells, immune infiltrates, stromal elements, vascular networks, and extracellular matrix components that collectively shape tumor progression and therapeutic response. Accumulating evidence demonstrates that the TME plays a decisive role in modulating anti-tumor immunity by fostering immune suppression, metabolic stress, and physical barriers that limit immune cell infiltration and function. This review provides a comprehensive overview of the cellular, molecular, metabolic, and epigenetic features of the TME that govern immune evasion and resistance to immunotherapy. We discuss the functional roles of key immune and stromal populations, including tumor-associated macrophages, myeloid-derived suppressor cells, regulatory T cells, cancer-associated fibroblasts, and endothelial cells, highlighting their contribution to immunosuppressive signaling networks. Furthermore, we examine how hypoxia, nutrient competition, immune checkpoint expression, and extracellular matrix remodeling impair effective anti-tumor immune responses. The review also summarizes current and emerging therapeutic strategies aimed at reprogramming the TME, including immune checkpoint blockade combinations, metabolic and epigenetic modulation, stromal targeting, and nanotechnology-based delivery systems. Finally, we highlight advances in single-cell, spatial, and multi-omics technologies that are transforming TME profiling and enabling precision immuno-oncology. A deeper understanding of TME-driven immune regulation is essential for overcoming therapeutic resistance and improving durable clinical outcomes in cancer patients.